You are here: Industry Insights > COVID-19 Vaccines

News List

Why are some COVID-19 vaccines working better for men than women? worldpharmanews
May 21, 2021
MSU researcher is studying, raising awareness about the role of sex in the efficacy of vaccines that make use of nanomedicine.
Are COVID-19 vaccines effective for immunocompromised patients with haematological malignancies? europeanpharmaceuticalreview
May 21, 2021
A new study will evaluate COVID-19 vaccines in patients with haematological malignancies who have received cellular therapy.
UK trial tests third doses of COVID-19 vaccines pharmatimes
May 20, 2021
A clinical trial has launched in the UK to test the safety and effectiveness of administering a third dose of seven different COVID-19 vaccines.
More pharma companies should be permitted to produce COVID-19 vaccines: Gadkari expresspharma
May 19, 2021
Instead of one company, 10 more companies should be allowed to make vaccines by paying 10 per cent royalty to the original patent holder of the vaccine, he said.
Over two billion doses of COVID-19 vaccines to be available between August to December 2021: Centre expresspharma
May 14, 2021
The Centre said that over two billion doses will be made available in the country in five months between August and December, enough to vaccinate the entire population.
Odisha to take global tender route to obtain COVID-19 vaccines: Chief Secretary SC Mohapatra expresspharma
May 12, 2021
Facing an acute shortage of COVID-19 vaccines, the Odisha government on Monday decided to float a global tender for procuring the vaccine to inoculate the states entire population, Chief Secretary SC Mohapatra said.
Paediatric and adolescent COVID-19 vaccines update europeanpharmaceuticalreview
May 07, 2021
The EMA is evaluating whether to lower the age at which Comirnaty can be administered and Novavax has begun testing its COVID-19 vaccine in paediatric patients.
US supports waiving IP for COVID vaccines pharmatimes
May 07, 2021
The Biden-Harris Administration has voiced support for waiving intellectual property protections for COVID vaccines, in the hope of ramping up access in low-income countries hit by the virus, marking a u-turn on the US' initial opposition to the move.
EMA and ECDC to collaborate on post-marketing monitoring of COVID-19 vaccines europeanpharmaceuticalreview
April 28, 2021
Under a new initiative, the EMA will monitor on the safety of marketed COVID-19 vaccines while the ECDC monitors their effectiveness in Europe.
Snowman Logistics and Spicejet sign MoU for COVID-19 vaccines distribution expresspharma
December 11, 2020
Snowman will handle the ground services while Spicejet provide the air connectivity for temperature-controlled distribution, across India and internationally.

Previous page 1 2 3 4 5 Next page